Author

Chirantan Ghosh

Observed institutions: Northwestern University, Creighton University, Scottsdale Community College, Geisinger Medical Center, Mayo Clinic, University of Miami, Missouri Valley Cancer Consortium, Dana-Farber Cancer Institute, Iowa Oncology Research Association, Rapid City Regional Hospital, St. Luke's Hospital, Hematology Oncology Associates, Sylvester Comprehensive Cancer Center, CentraCare Health System, University of Nebraska Medical Center, University of Pennsylvania

OpenAlex ID: A5109801584

A phase I study of radiation therapy and twice-weekly gemcitabine and cisplatin in patients with locally advanced pancreatic cancer

2003 · James A Martenson, Antonio P.G Vigliotti, et al. · International Journal of Radiation Oncology*Biology*Physics · 31

A Phase II Trial of 200% ProMACE-CytaBOM in Patients With Previously Untreated Aggressive Lymphomas: Analysis of Response, Toxicity, and Dose Intensity

1999 · Leo I. Gordon, Mary Young, et al. · Blood · 29

Phase II Study of High-Dose Somatostatin Analogue in Patients Either Previously Treated or Untreated Who Have Extensive-Stage Small Cell Lung Cancer

1999 · Robert F. Marschke, Joseph P. Grill, et al. · American Journal of Clinical Oncology · 24

Inhibition of 5 - fluorouracil-induced ocular irritation by ocular ice packs

1994 · Charles L. Loprinzi, Donald B. Wender, et al. · Cancer · 21

Leiomyosarcoma of the superior vena cava and azygos vein

1995 · James M. Levett, William G. Meffert, et al. · The Annals of Thoracic Surgery · 16

Phase II Evaluation of Continuous-Infusion 5-Fluorouracil, Leucovorin, Mitomycin-C, and Oral Dipyridamole in Advanced Measurable Pancreatic Cancer

2000 · Patrick A. Burch, Chirantan Ghosh, et al. · American Journal of Clinical Oncology · 13

Effects of a holistic, patient-centered approach on breast cancer relative dose intensity

2018 · Rebecca Louison, Jennifer Lee, et al. · Advances in Integrative Medicine · 4

Compliance with hormonal therapy

2016 · Henry J. Carson, Chirantan Ghosh · Breast Cancer Research and Treatment · 2

Holistic, patient-centered symptom management for metastatic cancer: A comparison pilot study

2020 · Rebecca R. Louison, Meleah Y. Baloch, et al. · Advances in Integrative Medicine

Works count: 9

Citation count: 140

H-index: 6

I10-index: 6